The archaeal Dps nanocage targets kidney proximal tubules via glomerular filtration

dc.contributor.authorUchida, Masaki
dc.contributor.authorMaier, Bernhard
dc.contributor.authorWaghwani, Hitesh Kumar
dc.contributor.authorSelivanovitch, Ekaterina
dc.contributor.authorPay, S. Louise
dc.contributor.authorAvera, John
dc.contributor.authorYun, EJun
dc.contributor.authorSandoval, Ruben M.
dc.contributor.authorMolitoris, Bruce A.
dc.contributor.authorZollman, Amy
dc.contributor.authorDouglas, Trevor
dc.contributor.authorHato, Takashi
dc.contributor.departmentMedicine, School of Medicineen_US
dc.date.accessioned2020-03-18T15:59:36Z
dc.date.available2020-03-18T15:59:36Z
dc.date.issued2019-09-03
dc.description.abstractNature exploits cage-like proteins for a variety of biological purposes, from molecular packaging and cargo delivery to catalysis. These cage-like proteins are of immense importance in nanomedicine due to their propensity to self-assemble from simple identical building blocks to highly ordered architecture and the design flexibility afforded by protein engineering. However, delivery of protein nanocages to the renal tubules remains a major challenge because of the glomerular filtration barrier, which effectively excludes conventional size nanocages. Here, we show that DNA-binding protein from starved cells (Dps) — the extremely small archaeal antioxidant nanocage — is able to cross the glomerular filtration barrier and is endocytosed by the renal proximal tubules. Using a model of endotoxemia, we present an example of the way in which proximal tubule–selective Dps nanocages can limit the degree of endotoxin-induced kidney injury. This was accomplished by amplifying the endogenous antioxidant property of Dps with addition of a dinuclear manganese cluster. Dps is the first-in-class protein cage nanoparticle that can be targeted to renal proximal tubules through glomerular filtration. In addition to its therapeutic potential, chemical and genetic engineering of Dps will offer a nanoplatform to advance our understanding of the physiology and pathophysiology of glomerular filtration and tubular endocytosis.en_US
dc.identifier.citationUchida, M., Maier, B., Waghwani, H. K., Selivanovitch, E., Pay, S. L., Avera, J., ... & Douglas, T. (2019). The archaeal Dps nanocage targets kidney proximal tubules via glomerular filtration. The Journal of Clinical Investigation, 129(9), 3941-3951. 10.1172/JCI127511en_US
dc.identifier.issn0021-9738en_US
dc.identifier.urihttps://hdl.handle.net/1805/22354
dc.language.isoen_USen_US
dc.publisherAmerican Society for Clinical Investigationen_US
dc.relation.isversionof10.1172/JCI127511en_US
dc.relation.journalThe Journal of Clinical Investigationen_US
dc.rightsPublisher Policyen_US
dc.sourcePMCen_US
dc.subjectNephrologyen_US
dc.subjectDiagnostic imagingen_US
dc.subjectDrug therapyen_US
dc.subjectNanotechnologyen_US
dc.titleThe archaeal Dps nanocage targets kidney proximal tubules via glomerular filtrationen_US
dc.typeArticleen_US
ul.alternative.fulltexthttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6715384/en_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
jci-129-127511.pdf
Size:
13.3 MB
Format:
Adobe Portable Document Format
Description:
Main article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: